Related Experiment Video
Updated: Apr 18, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Lower anti-echovirus antibody responses in children presenting to hospital with asthma exacerbations
Insights
Asthmatic children have lower antibody responses to gut-associated echoviruses but higher responses to respiratory rhinoviruses, suggesting a link between enterovirus immunity and asthma development. This indicates enteric infections may reduce asthma risk.
Area of Science:
- Immunology
- Virology
- Pediatrics
Background:
- Rhinoviruses (Enterovirus genus) induce high anticapsid antibodies in asthmatics.
- Gut-trophic echoviruses show diminished neutralizing antibodies in asthmatics.
- Enterovirus genus infections present differential antibody responses in asthmatics.
Purpose of the Study:
- Assess antibody titres to echovirus 30 and poliovirus 1 VP1 antigens in asthmatic and non-asthmatic children.
- Investigate the relationship between antibody titres and asthma status.
- Examine correlations with total IgE levels and other immune responses.
Main Methods:
- Produced recombinant VP1 capsid antigens for echovirus 30 and Sabin poliovirus 1.
- Quantitated IgG1 antibody binding in plasma from asthmatic (n=45) and non-asthmatic (n=29) children.
- Utilized immunoassays with immunoabsorptions to ensure specificity.
Main Results:
- Asthmatic children had significantly lower IgG1 antibody titres to echovirus 30 (P < 0.05).
- Echovirus 30 antibody titres inversely correlated with total IgE levels (r = -0.262; P < 0.05).
- No significant differences in antibody titres to Sabin poliovirus 1 were observed between groups.
Conclusions:
- Lower echovirus antibody titres in asthmatics, coupled with heightened rhinovirus response, suggest a dichotomy in enterovirus immunity and asthma risk.
- Respiratory enterovirus infection may increase asthma probability, while enteric infections might lower the risk.
- Supports the role of intestinal infections in allergic respiratory disease development.
Background:
Rhinoviruses from the Enterovirus genus cause frequent infections and induce remarkably high titres of anticapsid antigen antibodies in asthmatics, while the prevalence of neutralising antibodies to the gut-trophic echoviruses from the same genus is diminished.
Objective:
To assess the absolute and specific antibody titres to VP1 antigens of the gut-trophic enteroviruses, echovirus 30 and Sabin 1 poliovirus, in asthmatic and non-asthmatic children.
Methods:
Recombinant polypeptides representing the VP1 capsid antigens of echovirus 30 and Sabin poliovirus 1 were produced. Their ability to bind IgG1 antibodies from the plasma of asthmatic (n = 45) and non-asthmatic (n = 29) children were quantitated by immunoassays that incorporated immunoabsorptions to remove cross-reactivity.
Results:
The IgG1 antibody titres and prevalence of antibody binding to echovirus 30 were significantly lower for asthmatic children compared to controls (P < 0.05) and inversely correlated with total IgE levels for the whole study population (r = -0.262; P < 0.05). There was no difference in the prevalence and titre between groups to the VP1 antigen of Sabin poliovirus. Anti-tetanus toxoid titres measured for comparison did not correlate with anti-echovirus or poliovirus, but correlated with anti-rhinovirus titres in controls but not asthmatics, where the titres were higher for the asthmatic group.
Conclusions And Clinical Relevance:
The associations of lower antibody titres of asthmatic children to echovirus reported here and those of our previous findings of a heightened response to rhinovirus suggest a dichotomy where respiratory enterovirus infection/immunity increases the probability of developing asthma and enteric infections lower the risk. This provides further support for the concept of intestinal infection playing a key role in the development of allergic respiratory disease.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma I: Introduction
Cross-reactivity

